Small molecule inhibitors to reprogram the tumour environment and improve immunotherapy [ 2018 - ]

Research Grant

Researchers: Prof Ruth Ganss (Principal investigator) ,  Prof Gunter Hammerling

Brief description Cancer blood vessels are different to normal blood vessels; they help cancer cells to spread and stop immune cells in their tracks. We have identified drugs which help to make cancer blood vessels more normal and also bring immune cells into the cancer core. We will test these drugs in combination with immunotherapies, a new treatment option which has not reached its full potential in the clinic. Since our drug candidates are already in clinical use, we expect to fast track clinical development.

Funding Amount $784,520.00

Funding Scheme Project Grants

Notes Standard Project Grant